Successful treatment of fulminant pneumococcal sepsis with recombinant tissue plasminogen activator

By Akol H.   Boon E.S.   van Haren F.M.P.   van der Hoeven J.G.  

European Journal of Internal Medicine, Vol. 13, Iss. 6, 2002-09 ,pp. : 389-391

Elsevier

Access to resources Recommend Favorite

AMYLOID PEPTIDES STIMULATE TISSUE-TYPE PLASMINOGEN ACTIVATOR BUT NOT RECOMBINANT PROUROKINASE

By Wnendt S.   Wetzels I.   Gunzler W.A.  

Thrombosis Research, Vol. 85, Iss. 3, 1997-02 ,pp. : 217-224

Elsevier

Access to resources Recommend Favorite

Eligibility for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 22, Iss. 5-6, 2006-11 ,pp. : 423-428

Karger

Access to resources Recommend Favorite

Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in a Stroke Patient Treated with Dabigatran

By  

Cerebrovascular Diseases, Vol. 30, Iss. 5, 2010-09 ,pp. : 533-534

Karger

Access to resources Recommend Favorite

A Recombinant Antibody-Targeted Plasminogen Activator with High Affinity for Activated Platelets Increases Thrombolytic Potency in Vitro and in Vivo - Targeting of tissue plasminogen activator in vivo

By Wan H.   Liu Z.   Xia X.   Gu J.   Wang B.   Liu X.   Zhu M.   Li P.   Ruan C.  

Thrombosis Research, Vol. 97, Iss. 3, 2000-02 ,pp. : 133-141

Elsevier

Access to resources Recommend Favorite